Home › Therapeutic areas › Infectious Disease › Shigellosis

Shigellosis (1 companies)

Companies with an active program in Shigellosis.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
PCVX Vaxcyte Infectious Disease 1 Phase 3 $10.1B 7